ClinicalTrials.gg
RecruitingNCT07066631MOVINUpdated Oct 13, 2026

The Pregnancy and Postpartum Mental Health Optimization Virtual Intervention Network

An interventional study of Enhanced Usual Care and MOVIN Care Platform in Depression, Postpartum and Anxiety, sponsored by Women's College Hospital. Recruiting at 2 sites in Canada. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Women's College Hospital · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.
Updated Oct 13, 2026Site recruiting status changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
570
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 533 studies in Depression with a site in Canada — 107 open to participants now, 124 under way, 7 of them phase 3. Depression · Canada.

Planned enrollment
41st of 488
570 · median 77
Started
2025
with 39 others
No phase
334 of 533
78 open now
Primary completion
2028-09
later than 106 of 123 live
Registered
502nd of 533
by date

Among the 533 studies in Depression with a site in Canada, this one is the 41st largest by planned enrollment of the 488 interventional ones that give a count, is one of 40 that started in 2025, is one of 334 with no phase, reaches primary completion later than 106 of the 123 other live ones, and was the 502nd registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

107 of the 533 studies in Depression with a site in Canada are open now. Recruiting first, the newest first:

101 more — sign in →

All 107 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 533 studies in Depression with a site in Canada, or all of them as a file.
02

Study summary

Depression, anxiety, and related disorders such as post-traumatic stress and obsessive compulsive disorder affect about 20% of pregnant and postpartum people. When not treated properly, these issues negatively impact not only affected people, but also their children's health and development. Only 1 in 5 receive adequate treatment, so identifying new system-wide approaches to reliably deliver recommended care to perinatal mental health patients all is a crucial health care priority. The Pregnancy and Postpartum Mental health Optimization Virtual Intervention Network (MOVIN) is a scalable perinatal mental health platform building on the evidence-based Collaborative care delivery model. MOVIN's online platform allows patients to connect with a care coordinator to co-develop personalized treatment recommendations, in collaboration with their primary care clinician and a perinatal psychiatrist when needed; progress is tracked to re-evaluate.

Read the detailed description

The Pregnant and Postpartum Mental Health Optimization Virtual Intervention Network (MOVIN) is a model of stepped, collaborative care delivered virtually, accessible to pregnant and postpartum individuals across Ontario based at Women's College Hospital. Access to MOVIN includes access to a web platform with curated educational material and treatment resources, personalized treatment planning between a participant and the MOVIN Care Coordinator (informed by systematic measurement-based follow-up of mental health symptoms), liaison between the MOVIN Care Coordinator and the participant's primary care clinician, and direct referral to a perinatal psychiatrist if required. Participants will be allocated 1:1 (intervention: control) using a computer-generated random allocation sequence in randomly varying block sizes. The primary outcome will be depressive symptoms (considered as a continuous variable) at 24-weeks post-randomization, measured using the patient-reported Edinburgh Postnatal Depression Scale (EPDS). The main secondary outcome is symptom remission (EPDS \<10) at 24-weeks post-randomization.

03

Conditions studied

  • Depression
  • Postpartum
  • Anxiety
  • Pregnancy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adult (age 18 years or older)
  2. Pregnant or postpartum and living with their infant 0-6 months old. This includes all individuals who identify as women, as well as those of female sex who do not identify as women (e.g., non-binary, trans) who are the primary parent for their infant. This includes via natural birth, adoption, or surrogacy.
  3. EPDS score >10 at eligibility screening.

Exclusion criteria

Exclusion Criteria:

  1. Active alcohol or substance use disorder, mania or psychotic disorder (as these conditions are better managed in direct specialty care).
  2. Active suicide plan or intent (as emergent hospital-based care is likely required),
  3. Plan to move out of Ontario during the study.
  4. Unable to complete relevant study procedures and measures online. For the few participants without access to devices/home internet, we will budget for tablets/data plans.
  5. Unable to complete study activities in English. Note that Google translate is available for the intervention platform and language lines are available for participants so that they can be served in their language of choice, however we are unable to provide translations of all study assessment and questionnaire materials that participants will need to complete during the study.
  6. No primary care clinician (required for collaborative mental health care delivery model).
  7. Currently enrolled in a collaborative mental health care model.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
570 participants (estimated)

Study arms

  • Other
    Enhanced Usual Care

    Access to online resources and educational materials about general mental health, maternal mental health, depression and anxiety in the pregnancy and postpartum period, and an up-to-date listing of treatment services available in Ontario. These resources are maintained by the MOVIN study team.

    Other: Enhanced Usual Care

  • Experimental
    MOVIN

    Enhanced Usual Care plus MOVIN Care Platform. The MOVIN Care Platform is virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.

    Other: MOVIN Care Platform · Other: Enhanced Usual Care

Interventions

  • OtherEnhanced Usual Care

    Access to online resources and educational materials about general mental health, maternal mental health, depression and anxiety in the pregnancy and postpartum period, and an up-to-date listing of treatment services available in Ontario. These resources are maintained by the MOVIN study team.

  • OtherMOVIN Care Platform

    Virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.

  • OtherEnhanced Usual Care

    Access to online resources and educational materials about general mental health, maternal mental health, depression and anxiety in the pregnancy and postpartum period, and an up-to-date listing of treatment services available in Ontario. These resources are maintained by the MOVIN study team.

06

What researchers measure

Primary outcomes

  1. Depressive symptoms

    The primary objective of this trial is to determine the effect of MOVIN versus a control condition on perinatal depression symptoms. Depressive symptoms will be measured using the Edinburgh Postnatal Depressive Scale (EPDS), a self-report scale that has been validated for use in pregnancy and postpartum. EPDS scores range from 0 to 30.

    Time frame: 24 weeks post randomization

Secondary outcomes

  1. Maternal Remission of depression

    Depressive symptoms will be measured using the Edinburgh Postnatal Depressive Scale (EPDS), a self-report scale that has been validated for use in pregnancy and postpartum. EPDS scores range from 0 to 30. A EPDS score of \<10 indicates remission.

    Time frame: 24 weeks post randomization

  2. Maternal Depressive symptoms

    Depressive symptoms will be measured using the Edinburgh Postnatal Depressive Scale (EPDS), a self-report scale that has been validated for use in pregnancy and postpartum. EPDS scores range from 0 to 30.

    Time frame: 12 weeks post randomization

  3. Maternal Depressive symptoms

    Depressive symptoms will be measured using the Patient Health Questionnaire Scale (PHQ-9), a self-report scale that has been validated for use in pregnancy and postpartum. PHQ-9 scores range from 0 to 27.

    Time frame: 12 and 24 weeks post randomization

  4. Obsessive-Compulsive Inventory-Revised

    OCD symptoms will be measured using the Obsessive-Compulsive Inventory-Revised (OCI-R) Scale, a self-report scale that has been validated for use. OCI-R scores range from 0 to 72.

    Time frame: 12 and 24 weeks post randomization

  5. Maternal Posttraumatic Stress Disorder Checklist

    PTSD symptoms will be measured using the Posttraumatic Stress Disorder Checklist (PCL-5), a self report scale that has been validated to assess for PTSD symptoms. PCL-5 scores range from 0 to 80.

    Time frame: 12 and 24 weeks post randomization

  6. Maternal anxiety symptoms

    Anxiety symptoms will be measured using the General Anxiety Disorder-7 (GAD-7) scale, which is a self-report scale with good discriminate validity in perinatal populations. GAD-7 scores range from 0 to 21, with higher scores indicating more severe symptoms.

    Time frame: 12 and 24 weeks post randomization

  7. Maternal quality of life symptoms

    Quality of life will be measured using the 5 Level-5 Dimension EuroQol 5 (EQ-5D-5L) which is a multi-attribute utility instrument for measuring quality-adjusted life year (QALY), a preference-based utility measure of health-related quality of life as perceived by the patient. It can define 3125 different health states ranging from 11111 (full health) to 55555 (worst health).

    Time frame: 12 and 24 weeks post randomization

  8. Health service use: participant time

    Measured by participant self-report of activities related to attending appointments and obtaining services.

    Time frame: 12 and 24 weeks post randomization

  9. Health service use: participant cost

    Measured by participant self-report of costs related to attending appointments and obtaining services.

    Time frame: 12 and 24 weeks post randomization

  10. Health service use: health system costs

    Calculated from participant self-report of medical costs such as hospitalizations, visits with health professionals and medications.

    Time frame: 12 and 24 weeks post randomization

  11. Maternal child relationship

    All participants who are postpartum at any time point will complete Parenting Stress Index short form (PSI-SF) to measure parenting stress. This is a 36-item measure consisting of 3 sub-scales: parental distress, dysfunction in the parent-child relations and difficult child. Scores range from 36 to 180. Higher scores indicate higher levels of parenting stress.

    Time frame: If postpartum at enrollment: Baseline + 1y postpartum. If pregnant at enrollment: 1y postpartum

  12. Dyadic relationship

    The Dyadic Adjustment Scale (DAS) is a self-report measure of relationship adjustment with an intimate partner and will be used to measure relationship distress. The first 15 items of the 32-item measure will be used to assess dyadic consensus. Scores range from 0 to 75. Higher scores indicate a higher degree of dyadic consensus.

    Time frame: 12 and 24 weeks post randomization

  13. Child Development

    Assessed using the Ages \& Stages Questionnaire, Third Edition \[ASQ-3 (12 Months)\], and the Ages \& Stages Questionnaires: Social-Emotional, Second Edition \[(ASQ:SE-2 (12 Months)\]. A 30-item instrument that screens for child development at 11 months 0 days through 12 months 30 days and 9 months 0 days through 14 months 30 days, respectively. Scores are compared to norms. For the ASQ-3, the minimum value is 0 while the maximum value is 60. For the ASQ:SE-2, The minimum value is 0 while the maximum value is 155. A lower score indicates there may be a concern and further assessment from a professional may be needed, while a higher score indicates no concern and the child's development appears to be on track.

    Time frame: If postpartum at enrollment: Baseline + 1y postpartum. If pregnant at enrollment: 1y postpartum.

Other outcomes

  1. Clinician perspective survey

    Time frame: 24 weeks post randomization

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Sep 2028, 35 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 35 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 4, 2025
First posted
Jul 15, 2025
StartActual
Oct 29, 2025
Primary completionEst.
Sep 30, 2028
CompletionEst.
Mar 31, 2029
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
Women's College Hospital is now Recruiting
Oct 13, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Women's College Hospital · Toronto, CanadaContact added m•••@wchospital.ca · •••6400Contact added (no phone or email listed)Contact added (no phone or email listed)
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Women's College Hospital is now Recruiting
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Women's College Hospital · Toronto, CanadaContact added m•••@wchospital.ca · •••6400Contact added (no phone or email listed)Contact added (no phone or email listed)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07066631
Lead sponsor
Women's College Hospital
Responsible party
Sponsor
First posted
Jul 15, 2025
Start date
Oct 29, 2025
Primary completion
Sep 30, 2028 (estimated)
Completion
Mar 31, 2029 (estimated)
Last update
Oct 13, 2026

Study contacts

Simone Vigod
Contact
simone.vigod@wchospital.ca
416-323-6400 ext. 4080

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion